XM does not provide services to residents of the United States of America.

U.S. Albemarle, Nasdaq, Salesforce



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Albemarle, Nasdaq, Salesforce</title></head><body>

Sept 27 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Albemarle, Nasdaq and Salesforce on Friday.


HIGHLIGHTS

* Albemarle ALB.N: Jefferies cuts target price to $120 from $124

* Nasdaq Inc NDAQ.O: RBC initiates coverage with outperform rating; target price $88

* Salesforce Inc CRM.N: Wedbush raises target price to $325 from $315

Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.

* Albemarle ALB.N: Jefferies cuts target price to $120 from $124

* Autodesk Inc ADSK.O: D.A. Davidson initiates coverage with neutral rating; PT $260

* Bristol-Myers Squibb Co BMY.N: Jefferies raises target price to $57 from $53

* Carmax Inc KMX.N: RBC raises target price to $82 from $75

* CBOE Global Markets Inc CBOE.Z: RBC initiates coverage with sector perform rating; PT $220

* Celsius Holdings Inc CELH.O: Stephens cuts target price to $52 from $66

* Cintas Corp CTAS.O: Jefferies adjusts target price to $200 from $730 to reflect 4-for-1 stock split

* CME Group Inc CME.O: RBC initiates coverage with sector perform rating; PT $235

* Costco Wholesale Corp COST.O: D.A. Davidson raises target price to $880 from $780

* Costco Wholesale Corp COST.O: JP Morgan raises target price to $945 from $925

* Intercontinental Exchange Inc ICE.N: RBC initiates coverage with outperform rating; PT $200

* Jabil Inc JBL.N: JP Morgan raises target price to $144 from $133

* KB Home KBH.N: Raymond James raises target price to $93 from $81

* Metlife Inc MET.N: Jefferies raises target price to $95 from $89

* Nasdaq Inc NDAQ.O: RBC initiates coverage with outperform rating; target price $88

* Pfizer PFE.N: Jefferies cuts target price to $33 from $35

* Range Resources Corp RRC.N: JP Morgan raises target price to $33 from $31

* Salesforce Inc CRM.N: Wedbush raises target price to $325 from $315

* Scholar Rock Holding Corp SRRK.O: Wedbush raises target price to $25 from $23

* TD Synnex SNX.N: JP Morgan raises target price to $135 from $123

* T-Mobile TMUS.O: RBC raises target price to $232 from $200

* Vail Resorts Inc MTN.N: Jefferies cuts target price to $181 from $190

* VF Corp VFC.N: Jefferies initiates coverage With Hold rating; target price $20

* Wesco International Inc WCC.N: RBC raises target price to $187 from $171

* Zeta Global Holdings Corp ZETA.N: RBC raises target price to $34 from $29


(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.